
Yih-horng Shiao
Examiner (ID: 7187, Phone: (571)272-7135 , Office: P/1672 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1672, 1623, 1673, 1691, 1621, 1693 |
| Total Applications | 1088 |
| Issued Applications | 699 |
| Pending Applications | 98 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18221223
[patent_doc_number] => 20230060217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/885464
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885464
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885464 | Methods and compositions for increasing the potency of antifungal agents | Aug 9, 2022 | Issued |
Array
(
[id] => 19479800
[patent_doc_number] => 20240327842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => GALNAC-MONOMERS AND GALNAC-NUCLEIC ACID CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 18/681992
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681992
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/681992 | GALNAC-MONOMERS AND GALNAC-NUCLEIC ACID CONJUGATES | Aug 7, 2022 | Pending |
Array
(
[id] => 18581571
[patent_doc_number] => 20230263823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => FECES BINDER IN FEED FOR FISH
[patent_app_type] => utility
[patent_app_number] => 17/818073
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818073 | Feces binder in feed for fish | Aug 7, 2022 | Issued |
Array
(
[id] => 20059216
[patent_doc_number] => 20250197438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => IMMUNOREGULATORY AMIDE DERIVATIVE WITH IMPROVED MATERIAL PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 18/681029
[patent_app_country] => US
[patent_app_date] => 2022-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/681029 | IMMUNOREGULATORY AMIDE DERIVATIVE WITH IMPROVED MATERIAL PROPERTIES | Aug 2, 2022 | Pending |
Array
(
[id] => 19496448
[patent_doc_number] => 20240335466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR USE IN THE TREATMENT OF SAPHO SYNDROME
[patent_app_type] => utility
[patent_app_number] => 18/292620
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292620
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292620 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR USE IN THE TREATMENT OF SAPHO SYNDROME | Aug 1, 2022 | Pending |
Array
(
[id] => 19447296
[patent_doc_number] => 20240307426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS
[patent_app_type] => utility
[patent_app_number] => 18/578207
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578207
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/578207 | USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS | Jul 25, 2022 | Pending |
Array
(
[id] => 18391363
[patent_doc_number] => 20230159581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/873451
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873451
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873451 | NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS | Jul 25, 2022 | Abandoned |
Array
(
[id] => 18034597
[patent_doc_number] => 20220378812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => TOPICAL ANALGESIC
[patent_app_type] => utility
[patent_app_number] => 17/813676
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813676 | Topical analgesic | Jul 19, 2022 | Issued |
Array
(
[id] => 18404466
[patent_doc_number] => 20230165817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => DOPAMINERGIC MIMETICS
[patent_app_type] => utility
[patent_app_number] => 17/811956
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811956
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811956 | DOPAMINERGIC MIMETICS | Jul 11, 2022 | Abandoned |
Array
(
[id] => 19402163
[patent_doc_number] => 20240285674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => USE OF SULFATE GLUCO-GALACTO-OLIGOSACCHARIDE IN PREPARATION OF ANTICOAGULANT AND/OR ANTITHROMBOTIC DRUG
[patent_app_type] => utility
[patent_app_number] => 18/577953
[patent_app_country] => US
[patent_app_date] => 2022-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18577953
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/577953 | USE OF SULFATE GLUCO-GALACTO-OLIGOSACCHARIDE IN PREPARATION OF ANTICOAGULANT AND/OR ANTITHROMBOTIC DRUG | Jul 3, 2022 | Pending |
Array
(
[id] => 19667793
[patent_doc_number] => 12180526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Subterranean microalgae for production of microbial biomass, substances, and compositions
[patent_app_type] => utility
[patent_app_number] => 17/810522
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 27950
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810522
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810522 | Subterranean microalgae for production of microbial biomass, substances, and compositions | Jun 30, 2022 | Issued |
Array
(
[id] => 19884092
[patent_doc_number] => 12269784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Biomass production
[patent_app_type] => utility
[patent_app_number] => 18/567332
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 23318
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567332 | Biomass production | Jun 30, 2022 | Issued |
Array
(
[id] => 18389821
[patent_doc_number] => 20230158039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => BROMODOMAIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/810313
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 626
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810313 | BROMODOMAIN INHIBITORS | Jun 29, 2022 | Abandoned |
Array
(
[id] => 20770158
[patent_doc_number] => 12653810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-16
[patent_title] => Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
[patent_app_type] => utility
[patent_app_number] => 17/851684
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 127301
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851684 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease | Jun 27, 2022 | Issued |
Array
(
[id] => 18169375
[patent_doc_number] => 20230035986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => NOVEL CROSSLINKED ALGINIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/842115
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842115
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842115 | Crosslinked alginic acid | Jun 15, 2022 | Issued |
Array
(
[id] => 18169287
[patent_doc_number] => 20230035898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => CYCLODEXTRIN PROTEIN DRUG CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/837598
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837598
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837598 | Cyclodextrin protein drug conjugates | Jun 9, 2022 | Issued |
Array
(
[id] => 17881246
[patent_doc_number] => 20220296723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PROCESSES FOR THE FORMULATION OF PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/806107
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806107
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806107 | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein | Jun 8, 2022 | Issued |
Array
(
[id] => 18018816
[patent_doc_number] => 20220370315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => TOPICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/835935
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835935 | Topical compositions | Jun 7, 2022 | Issued |
Array
(
[id] => 19762191
[patent_doc_number] => 12220462
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-02-11
[patent_title] => Complexes for delivery of cyclic dinucleotides
[patent_app_type] => utility
[patent_app_number] => 17/826633
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 44007
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826633
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826633 | Complexes for delivery of cyclic dinucleotides | May 26, 2022 | Issued |
Array
(
[id] => 18460340
[patent_doc_number] => 11684618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Compositions comprising mixtures of compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/747440
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15538
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17747440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/747440 | Compositions comprising mixtures of compounds and uses thereof | May 17, 2022 | Issued |